ZENA ZENA
Company Profile ↓Company Overview
ZENA (ZENA) is a publicly traded company listed on with a market capitalization of $61.47M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 62.2% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.32.
Recent Developments
- Dec 2025 Revenue of $12.91M (+557.6% YoY); net profit $-45.22M.
- Trailing 12 Months Year-on-year growth — revenue +557.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 62.2%, profit CAGR -105614.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 62.21% |
| 1 Year: | 557.60% |
Compounded Profit Growth
| 5 Years: | -105,613.97% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -70.84% |
| 6 Months: | -66.75% |
| 3 Months: | -43.36% |
| 1 Month: | -11.72% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)39.25 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 62.2% over 5 years.
CONS
- Earnings shrank at -105614.0% CAGR over 5 years.
- Trading 80.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.14M | 2.24M | 4.35M | 5.19M | 8.40M |
| Cost of Revenue | - | 897.90K | 3.01M | 5.20M | 8.16M | 10.54M |
| Gross Profit | - | 237.75K | -768.87K | -850.72K | -2.97M | -2.13M |
| Operating Expenses | - | 3.23M | 3.14M | 3.95M | 10.65M | 19.44M |
| Operating Income | - | -2.99M | -3.91M | -4.80M | -13.62M | -21.57M |
| EBITDA | - | -2.86M | -3.31M | -4.57M | -12.41M | -20.09M |
| Interest Expense | - | 1.63M | 2.56M | 7.28M | 8.42M | 5.08M |
| Pretax Income | - | -4.61M | -6.12M | -12.27M | -22.21M | -26.55M |
| Tax Provision | 0 | - | - | - | - | - |
| Net Income | - | -4.61M | -6.12M | -12.27M | -22.21M | -26.55M |
| Diluted EPS | - | -0.25 | -0.19 | -0.34 | - | -0.50 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 3.03M | 1.83M | 1.96M | 12.91M |
| Cost of Revenue | - | 1.70M | 802.17K | 819.22K | 17.70M |
| Gross Profit | - | 1.32M | 1.03M | 1.14M | -4.78M |
| Operating Expenses | - | 975.25K | 781.04K | 4.16M | 20.54M |
| Operating Income | - | 345.48K | 244.53K | -3.01M | -25.32M |
| EBITDA | - | 464.87K | 487.87K | -2.75M | -23.16M |
| Interest Expense | - | 219.14K | 470.49K | 1.45M | 19.88M |
| Pretax Income | - | -1.18K | -245.68K | -4.48M | -45.22M |
| Tax Provision | -5.76K | -15.45K | -4.17K | 0 | - |
| Net Income | - | 14.28K | -241.50K | -4.48M | -45.22M |
| Diluted EPS | - | 0.00 | -0.01 | -0.22 | -1.32 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 13.54M | 16.45M | 34.65M | 99.76M |
| Current Assets | - | 2.87M | 2.57M | 6.28M | 33.21M |
| Cash & Equivalents | - | 200.79K | 1.18K | 3.75M | 5.98M |
| Inventory | - | - | - | 0 | 2.84M |
| Receivables | - | 121.12K | 46.45K | 206.43K | 4.17M |
| Total Liabilities | - | 5.97M | 9.13M | 12.83M | 31.80M |
| Current Liabilities | - | 1.12M | 1.08M | 2.89M | 14.96M |
| Long Term Debt | - | 4.84M | 7.86M | 9.78M | 13.57M |
| Total Debt | - | 4.97M | 8.24M | 10.12M | 21.46M |
| Total Equity | - | 7.57M | 7.32M | 21.82M | 67.96M |
| Shares Outstanding | - | 17.66M | 17.66M | 25.10M | 48.02M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -1.86M | -1.98M | -9.83M | -35.46M |
| Investing Cash Flow | - | -1.34M | -923.80K | -1.93M | -29.32M |
| Financing Cash Flow | - | 1.96M | 2.81M | 14.88M | 67.46M |
| Capital Expenditure | - | -800.67K | -604.16K | -1.45M | -10.22M |
| Free Cash Flow | - | -2.66M | -2.58M | -11.28M | -45.68M |
| Net Change in Cash | - | -1.24M | -89.61K | 3.12M | 2.69M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 43.7% | 56.1% | 58.3% | -37.0% |
| Operating Margin % | - | 11.4% | 13.4% | -153.5% | -196.1% |
| Net Margin % | - | 0.5% | -13.2% | -228.2% | -350.2% |
| ROE % | - | 0.2% | -3.3% | -20.5% | -66.5% |
| ROCE % | - | 2.8% | 1.6% | -9.5% | -29.9% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ZENA
ZENA — Frequently Asked Questions
What is the current share price of ZENA?
As of 2026-08-02 19:16 PDT, ZENA trades at $1.28 on NASDAQ/NYSE. Its 52-week range is $1.24 to $6.69.
What is the market capitalisation of ZENA?
ZENA has a market capitalisation of $61.47M on NASDAQ/NYSE.
What is the P/E ratio of ZENA?
ZENA trades at a trailing price-to-earnings (P/E) ratio of -0.97. Its price-to-book (P/B) ratio is 0.90.
What is the return on equity (ROE) of ZENA?
ZENA has a return on equity (ROE) of -66.53%. Its return on capital employed (ROCE) is -29.88%.
Is ZENA a good stock to buy?
This page provides a data-driven analysis of ZENA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.